Cargando…

Ethanol/Naltrexone Interactions at the mu-Opioid Receptor. CLSM/FCS Study in Live Cells

BACKGROUND: Alcoholism is a widespread chronic disorder of complex aetiology with a significant negative impact on the individual and the society. Mechanisms of ethanol action are not sufficiently well understood at the molecular level and the pharmacotherapy of alcoholism is still in its infancy. O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vukojević, Vladana, Ming, Yu, D'Addario, Claudio, Rigler, Rudolf, Johansson, Björn, Terenius, Lars
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2008
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2602977/ https://www.ncbi.nlm.nih.gov/pubmed/19104662 http://dx.doi.org/10.1371/journal.pone.0004008

Ejemplares similares

Mapping the Direction of Nucleocytoplasmic Transport of Glucocorticoid Receptor (GR) in Live Cells Using Two-Foci Cross-Correlation in Massively Parallel Fluorescence Correlation Spectroscopy (mpFCS)
por: Nikolić, Stanko N., et al.
Publicado: (2023)

BioShuttle Mobility in Living Cells Studied with High-Resolution FCS & CLSM Methodologies
por: Braun, Klaus, et al.
Publicado: (2012)

Naltrexone blocks alcohol-induced effects on kappa-opioid receptors in the plasma membrane
por: Terenius, Lars, et al.
Publicado: (2023)

Nanoscale Effects of Ethanol and Naltrexone on Protein Organization in the Plasma Membrane Studied by Photoactivated Localization Microscopy (PALM)
por: Tobin, Steven J., et al.
Publicado: (2014)

Dynamic Cellular Cartography: Mapping the Local Determinants of Oligodendrocyte Transcription Factor 2 (OLIG2) Function in Live Cells Using Massively Parallel Fluorescence Correlation Spectroscopy Integrated with Fluorescence Lifetime Imaging Microscopy (mpFCS/FLIM)
por: Oasa, Sho, et al.
Publicado: (2021)

A strategy for designing allosteric modulators of transcription factor dimerization
por: Oasa, Sho, et al.
Publicado: (2020)

Non-Peptide Opioids Differ in Effects on Mu-Opioid (MOP) and Serotonin 1A (5-HT(1A)) Receptors Heterodimerization and Cellular Effectors (Ca(2+), ERK1/2 and p38) Activation
por: Radoi, Vlad, et al.
Publicado: (2022)

Control of Hox transcription factor concentration and cell-to-cell variability by an auto-regulatory switch
por: Papadopoulos, Dimitrios K., et al.
Publicado: (2019)

Amyloidogenic Nanoplaques in Blood Serum of Patients with Alzheimer’s Disease Revealed by Time-Resolved Thioflavin T Fluorescence Intensity Fluctuation Analysis
por: Tiiman, Ann, et al.
Publicado: (2019)

Anhedonia to music and mu-opioids: Evidence from the administration of naltrexone
por: Mallik, Adiel, et al.
Publicado: (2017)

Dynamic lateral organization of opioid receptors (kappa, mu(wt) and mu(N40D)) in the plasma membrane at the nanoscale level
por: Rogacki, Maciej K., et al.
Publicado: (2018)

Fluorescence-based monitoring of electronic state and ion exchange kinetics with FCS and related techniques: from T-jump measurements to fluorescence fluctuations
por: Rigler, Rudolf, et al.
Publicado: (2017)

Iso-α-acids in Nonalcoholic and Alcoholic Beer Stimulate Growth of Neuron-like SH-SY5Y Cells and Neuroepithelial Stem Cells
por: Laurent, Agneta J., et al.
Publicado: (2021)

Naltrexone is neuroprotective against traumatic brain injury in mu opioid receptor knockout mice
por: Wang, Yu‐Syuan, et al.
Publicado: (2021)

Sustainability of FCs
por: Losito, Roberto
Publicado: (2023)

Naltrexone Implant for Opioid Use Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021)

The interwoven fibril-like structure of amyloid-beta plaques in mouse brain tissue visualized using super-resolution STED microscopy
por: Johansson, Björn, et al.
Publicado: (2023)

Small Molecule Decoys of Aggregation for Elimination of Aβ-Peptide Toxicity
por: Oasa, Sho, et al.
Publicado: (2023)

Preclinical and Clinical Evidence for a Distinct Regulation of Mu Opioid and Type 1 Cannabinoid Receptor Genes Expression in Obesity
por: Pucci, Mariangela, et al.
Publicado: (2019)

Microvascular engineering in perfusion culture: immunohistochemistry and CLSM findings
por: Frerich, Bernhard, et al.
Publicado: (2006)

Whose mu fared better? The effect of extended-release naltrexone (XR-NTX) on treatment outcomes for opioid and alcohol users
por: Crèvecoeur-MacPhail, Desirée A
Publicado: (2015)

Comparison of Cerebrospinal Fluid Amyloidogenic Nanoplaques With Core Biomarkers of Alzheimer’s Disease
por: Aksnes, Mari, et al.
Publicado: (2021)

Adaptive optics allows STED-FCS measurements in the cytoplasm of living cells
por: Barbotin, Aurélien, et al.
Publicado: (2019)

Combined FCS and PCH Analysis to Quantify Protein Dimerization in Living Cells
por: Nederveen-Schippers, Laura M., et al.
Publicado: (2021)

Serum Amyloidogenic Nanoplaques and Cytokines in Alzheimer’s Disease: Pilot Study in a Small Naturalistic Memory Clinic Cohort
por: Aksnes, Mari, et al.
Publicado: (2022)

An analysis of the effect of mu-opioid receptor gene (OPRM1) promoter region DNA methylation on the response of naltrexone treatment of alcohol dependence
por: Lin, Yufei, et al.
Publicado: (2020)

Developments of FCS-link interface cards
por: Rubin, G, et al.
Publicado: (1996)

Measurement of nanoscale three-dimensional diffusion in the interior of living cells by STED-FCS
por: Lanzanò, Luca, et al.
Publicado: (2017)

AFM, ESEM, TEM, and CLSM in liposomal characterization: a comparative study
por: Ruozi, Barbara, et al.
Publicado: (2011)

Pharmacological enhancement of naltrexone treatment for opioid dependence: a review
por: Mannelli, Paolo, et al.
Publicado: (2011)

Long-Acting Injectable Naltrexone for the Management of Patients with Opioid Dependence
por: Kjome, Kimberly L., et al.
Publicado: (2011)

Naltrexone extended-release injection: an option for the management of opioid abuse
por: Taylor, Robert, et al.
Publicado: (2011)

The Effects of Low Dose Naltrexone on Opioid Induced Hyperalgesia and Fibromyalgia
por: Jackson, Daniel, et al.
Publicado: (2021)

Characterisation of patients with familial chylomicronaemia syndrome (FCS) and multifactorial chylomicronaemia syndrome (MCS): Establishment of an FCS clinical diagnostic score
por: Moulin, Philippe, et al.
Publicado: (2018)

Naltrexone Reverses Ethanol-Induced Rat Hippocampal and Serum Oxidative Damage
por: Almansa, Inmaculada, et al.
Publicado: (2013)

Molecular Diffusion of ABCA1 at the Cell Surface of Living Cells Assessed by svFCS
por: Raducka-Jaszul, Olga, et al.
Publicado: (2021)

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
por: Aksnes, Mari, et al.
Publicado: (2021)

GPR37 and GPR37L1 differently interact with dopamine 2 receptors in live cells
por: Hertz, E., et al.
Publicado: (2019)

Measuring Mobility in Chromatin by Intensity-Sorted FCS
por: Di Bona, Melody, et al.
Publicado: (2019)

CLSM as Quantitative Method to Determine the Size of Drug Crystals in a Solid Dispersion
por: de Waard, Hans, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_regq3edufn95jlg1iu0a292pf2